Author reply: To PMID 23084240
Ophthalmology
.
2014 Jan;121(1):e5-6.
doi: 10.1016/j.ophtha.2013.09.018.
Epub 2013 Nov 18.
Authors
Jeffrey S Heier
1
,
David M Brown
2
,
Victor Chong
3
,
Jean-Francois Korobelnik
4
,
Peter K Kaiser
5
,
Quan Dong Nguyen
6
,
Bernd Kirchhof
7
,
Allen Ho
8
,
Yuichiro Ogura
9
,
Ursula Schmidt-Erfurth
10
Affiliations
1
Ophthalmic Consultants of Boston and Tufts University School of Medicine, Boston, Massachusetts.
2
Retina Consultants of Houston, Houston, Texas.
3
Oxford Eye Hospital, University of Oxford, Oxford, United Kingdom.
4
CHU de Bordeaux - Université Bordeaux 2, Bordeaux, France.
5
Cole Eye Institute, Cleveland, Ohio.
6
Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, Nebraska.
7
University of Cologne, Cologne, Germany.
8
Wills Eye Hospital, Philadelphia, Pennsylvania.
9
Nagoya City University, Nagoya, Japan.
10
Department of Ophthalmology, Medical University of Vienna, Vienna, Austria.
PMID:
24256893
DOI:
10.1016/j.ophtha.2013.09.018
No abstract available
Publication types
Letter
Comment
MeSH terms
Female
Humans
Male
Recombinant Fusion Proteins / therapeutic use*
Wet Macular Degeneration / drug therapy*
Substances
Recombinant Fusion Proteins